Advertisement
Screener

PUMA BIOTECHNOLOGY, INC. (PBYI) Adjustment of Warrants Granted for Services

PUMA BIOTECHNOLOGY, INC. Adjustment of Warrants Granted for Services

PUMA BIOTECHNOLOGY, INC. (PBYI) reported Adjustment of Warrants Granted for Services of $25.81 million for the 48-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2015-03-02

  • PUMA BIOTECHNOLOGY, INC. adjustment of warrants granted for services for the quarter ending 2014-09-30 was $0.00.
  • PUMA BIOTECHNOLOGY, INC. adjustment of warrants granted for services for the quarter ending 2014-03-31 was $0.00.
  • PUMA BIOTECHNOLOGY, INC. adjustment of warrants granted for services for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
  • PUMA BIOTECHNOLOGY, INC. adjustment of warrants granted for services for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
  • PUMA BIOTECHNOLOGY, INC. adjustment of warrants granted for services for fiscal 2012 was $18.22M, a 140.21% increase from fiscal 2011.
  • PUMA BIOTECHNOLOGY, INC. adjustment of warrants granted for services for fiscal 2011 was $7.59M.
Period endAdjustment of Warrants Granted for Services 3 monthAdjustment of Warrants Granted for Services 3 month as first filedAdjustment of Warrants Granted for Services 6 monthAdjustment of Warrants Granted for Services 6 month as first filedAdjustment of Warrants Granted for Services 9 monthAdjustment of Warrants Granted for Services 9 month as first filedAdjustment of Warrants Granted for Services 12 monthAdjustment of Warrants Granted for Services 12 month as first filedAdjustment of Warrants Granted for Services 16 monthAdjustment of Warrants Granted for Services 18 monthAdjustment of Warrants Granted for Services 21 monthAdjustment of Warrants Granted for Services 25 monthAdjustment of Warrants Granted for Services 27 monthAdjustment of Warrants Granted for Services 30 monthAdjustment of Warrants Granted for Services 33 monthAdjustment of Warrants Granted for Services 36 monthAdjustment of Warrants Granted for Services 39 monthAdjustment of Warrants Granted for Services 42 monthAdjustment of Warrants Granted for Services 45 monthAdjustment of Warrants Granted for Services 48 month
2014-09-30$0.00
derived: 10-Q 48 month − 10-Q 45 month · filed 2014-11-10
$25.81M
10-Q · filed 2014-11-10
2014-06-30$25.81M
10-Q · filed 2014-08-11
2014-03-31$0.00
derived: 10-Q 42 month − 10-K 39 month · filed 2014-05-12
$0.00
derived: sum of 2 quarters · filed 2014-05-12
$0.00
derived: sum of 3 quarters · filed 2014-05-12
$0.00
derived: sum of 4 quarters · filed 2014-05-12
$25.81M
10-Q · filed 2014-05-12
2013-12-31$0.00
derived: 10-K 39 month − 10-Q 36 month · filed 2014-03-03
$0.00
derived: sum of 2 quarters · filed 2014-03-03
$0.00
derived: sum of 3 quarters · filed 2014-03-03
$0.00
derived: sum of 4 quarters · filed 2014-03-03
$25.81M
10-K · filed 2014-03-03
2013-09-30$0.00
derived: 10-Q 36 month − 10-Q 33 month · filed 2013-11-12
$0.00
derived: sum of 2 quarters · filed 2013-11-12
$0.00
derived: sum of 3 quarters · filed 2013-11-12
$11.97M
derived: sum of 4 quarters · filed 2015-03-02
$25.81M
10-Q · filed 2013-11-12
2013-06-30$0.00
derived: 10-Q 33 month − 10-Q 30 month · filed 2013-08-06
$0.00
derived: sum of 2 quarters · filed 2013-08-06
$11.97M
derived: sum of 3 quarters · filed 2015-03-02
$18.44M
derived: sum of 4 quarters · filed 2015-03-02
$25.81M
10-Q · filed 2013-08-06
2013-03-31$0.00
derived: 10-Q 30 month − 10-K 27 month · filed 2013-05-09
$11.97M
derived: sum of 2 quarters · filed 2015-03-02
$18.44M
derived: sum of 3 quarters · filed 2015-03-02
$18.37M
derived: sum of 4 quarters · filed 2015-03-02
$25.81M
10-Q · filed 2013-05-09
2012-12-31$11.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$18.44M
derived: sum of 2 quarters · filed 2015-03-02
$18.37M
derived: sum of 3 quarters · filed 2015-03-02
$18.22M
10-K · filed 2015-03-02
$25.81M
10-K · filed 2013-04-01
2012-09-30$6.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$6.40M
derived: sum of 2 quarters · filed 2013-11-12
$6.25M
10-Q · filed 2013-11-12
$6.25M
10-Q · filed 2012-11-14
$13.84M
10-Q · filed 2012-11-14
2012-06-30-$66.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
-$215.00K
10-Q · filed 2013-08-06
-$214.59K
10-Q · filed 2012-08-14
$7.37M
10-Q · filed 2012-08-14
2012-03-31-$149.00K
10-Q · filed 2013-05-09
-$149.28K
10-Q · filed 2012-05-15
$7.44M
10-Q · filed 2012-05-15
2011-12-31$7.59M
10-K · filed 2014-03-03
$7.59M
10-K · filed 2012-03-29
$7.59M
10-K · filed 2012-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARVINAS, INC. (ARVN)United States$0.510B58.38
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Evolus, Inc. (EOLS)United States$0.519B-13.32
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76